Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Ryan P. Goepfert Image

      Ryan P. Goepfert, MD, FACS

      Department of Head and Neck Surgery, Division of Surgery

      About Dr. Ryan P. Goepfert

      Dr. Ryan P. Goepfert is an Associate Professor and Director of the Head and Neck Surgical Oncology Fellowship at MD Anderson Cancer Center in Houston, Texas. Dr. Goepfert's clinical expertise is in melanoma and sarcoma, including in the pediatric population, as well as the surgical management of oropharynx cancer with transoral robotic surgery. Dr. Goepfert’s research efforts focus on functional and patient-reported outcomes in the multidisciplinary management of oropharyngeal carcinoma.








      Read More

      Meet Ryan Goepfert, M.D.

      In the News

      Young person with eyes closed holding a drawing of cartoon gum cancer in front of her mouth

      Cancer of the gums: 9 things to know

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, TX

      Assistant Professor, Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Clinical Associate Professor, Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX

      Clinical Associate Professor, University of Houston, Houston, Texas

      Associate Professor, Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2010Baylor College of Medicine, Houston, Texas, US, MD
      2006Vanderbilt University, Nashville, Tennessee, US, BA in Philosophy

      Postgraduate Training

      2016-2017Clinical Fellowship, Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas
      2015-2016Research Fellowship, Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas
      2010-2015Clinical Residency, Otolaryngology - Head and Neck Surgery, University of California, San Francisco, San Francisco, California

      Licenses & Certifications

      2016DEA
      2016American Board of Otolaryngology
      2015Texas Medical Board

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Head & Neck Surgery/ Head & Neck Reconstructive Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

      Fellowship Program Associate Director, Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, TX, 2020 - 2022

      Other Professional Positions

      Member, Head and Neck Surgery Education Committee, Houston, TX, 2018 - Present

      Extramural Institutional Committee Activities

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2018 - 2021

      Member, Focus on Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2018 - 2021

      Honors & Awards

      2022 - 20242022 Distinguished Educator of the Year Award, Advanced Head and Neck Surgical Oncology Fellowship
      2022 - 2023Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) 2022 Top 1% Performer, Press Ganey
      2021Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) 2021 Top 10% Performer, Press Ganey
      2020Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) 2020 Top 1% Performer, Press Ganey
      2015The Shirley K. Baron, MD Resident Research Award, The Triological Society
      2015The Kelvin C. Lee Resident Award for Outstanding and Meritorious Service and Team Leadership, University of California – San Francisco, Department of Otolaryngology - Head and Neck Surgery
      2015Resident Travel Grant, The Triological Society
      2013Resident Travel Grant, American Academy of Otolaryngology – Head and Neck Surgery Foundation
      2011Julius R. Krevans Award for Clinical Excellence, University of California – San Francisco
      2010Gold Humanism Honor Society, Baylor College of Medicine
      2010Doctor of Medicine with Honor, Baylor College of Medicine
      2006Summa Cum Laude, Vanderbilt University
      2006Phi Beta Kappa - Alpha of Tennessee, Vanderbilt University

      Professional Memberships

      American College of Surgeons

      2017 - Present

      Harris County Medical Society

      2017 - Present

      American Society of Clinical Oncology

      2017 - Present

      Houston Society of Otolaryngology - Head and Neck Surgery

      2017 - Present

      Texas Medical Association

      2015 - Present

      American Head and Neck Society

      2010 - Present

      American Academy of Otolaryngology – Head and Neck Surgery

      2010 - Present

      Gold Humanism Honor Society

      2010 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Surgical Management of Oral Cavity and Oropharyngeal Cancer. Invited. Houston, US.
      2. 2024. HNS Core Lecture on Melanoma. Invited. Houston, Texas, US.
      3. 2022. Creation and classification of the laryngectomy stoma (STOMA). Conference. MD Anderson, US.
      4. 2022. TORS in the management of OPC. Conference. MDA Cancer Network, US.
      5. 2022. Surgical Management of Oral Cavity and Oropharyngeal Cancer. Conference. MD Anderson, US.
      6. 2022. Elective laryngectomy for late-RAD. Conference. MD Anderson, US.
      7. 2022. Management of Cutaneous Melanoma. Conference. BCM, US.
      8. 2022. The Art and Science of Managing the New Melanoma Landscape - Case Based Discussion. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      9. 2021. Surgical considerations for the pharynx and neck in total laryngectomy. Conference. MD Anderson, US.
      10. 2021. Surgical Management of Oral Cavity and Oropharyngeal Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      11. 2020. Surgical Decision-making in Head and Neck Cutaneous Melanoma. Conference. MD Anderson, US.
      12. 2020. Functional Outcomes in OPC. Conference. MD Anderson, US.
      13. 2020. Emergent Airway Management in Advanced Head and Neck Cacner. Conference. MD Anderson, US.
      14. 2019. Evidence-Based Advocacy for TORS in OPC. Conference. MD Anderson, US.
      15. 2019. Management of Cutaneous Melanoma of the Head and Neck. Conference. MD Anderson, US.
      16. 2019. Sentinel Lymph Node Biopsy for Head and Neck Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      17. 2018. Epidemic of HPV-related Oropharyngeal Cancers. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.

      National Presentations

      1. 2025. Current Management of Cutaenous Melanoma. Invited, US.
      2. 2022. Cutaneous Melanoma Case Presentation. Conference. AHNS, US.
      3. 2021. Evolution of Surgical Decision-making in Stage III Melanoma and Advanced cSCC. Conference. ASTRO. Chicago, US.
      4. 2020. Cutaneous SCC Case Presentation. Conference. AHNS, US.
      5. 2019. Adjuvant Treatment Decision-Making after TORS. Invited. AAO-HNS. New Orleans, US.
      6. 2019. Evidence-Based Adjuvant Therapy after TORS for HPV+ Oropharynx Carcinoma. Invited. AHNS. New Orleans, US.
      7. 2019. Functional Outcomes after Transoral Robotic Surgery. Invited. ICORL. Seoul.
      8. 2019. Sentinel Lymph Node Biopsy for Head and Neck Melanoma. Conference. Orbital Oncology Conference. Houston, TX, US.
      9. 2015. Poster Presentation: Prospective MD Anderson Dysphagia Inventory Outcomes after Non-Surgical Treatment of Locoregionally Advanced Oropharyngeal Carcinoma. Conference. Multidisciplinary Head and Neck Cancer Symposium. Scottsdale, AZ, US.
      10. 2015. Poster Presentation: Long-term Performance of the MD Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma after Intensity Modulated Radiation Therapy. Conference. Multidisciplinary Head and Neck Cancer Symposium. Scottsdale, AZ, US.
      11. 2015. Poster Presentation: Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma. Conference. Triological Society Combined Sections Meeting. Coronado, CA, US.
      12. 2013. Poster Presentation: Retrognathia and Ankyloglossia: A Case Report and Considerations for Evaluation and Management. Conference. American Society of Pediatric Otolaryngology Spring Meeting, US.
      13. 2013. Poster Presentation: Oral Tongue Squamous Cell Carcinoma in Young Women – Outcomes and Clinicopathologic Comparison. Conference. Triological Society Combined Sections Meeting. Scottsdale, AZ, US.

      International Presentations

      1. 2025. TORS. OPC Conference, CL.
      2. 2023. Dysphagia after Chemoradiation. Conference. Netherlands Cancer Institute. Amsterdam, NL.
      3. 2023. TEP Outcomes. Conference. Netherlands Cancer Institute. Amsterdam, NL.
      4. 2023. Surgical Technique to Mitigate Complications and Optimize Functional Rehabilitation in Total Laryngectomy. Conference. AHNS. Montreal, CA.
      5. 2019. Mucosal Melanoma of the Head and Neck. Invited. Oncosalud. Lima, PE.
      6. 2019. Adjuvant Therapy and Functional Outcomes in Oropharyngeal Carcinoma Evidence-based Advocacy for Transoral Surgery. Invited. TSOHNS. Kaoshiung, TW.
      7. 2019. Anesthetic Considerations in Transoral Robotic Surgery. Invited. INCAN. Mexico City, MX.
      8. 2019. Evidence-Based Approach to Transoral Robotic Surgery (TORS) in Oropharyngeal Carcinoma. Invited. FORL. Sao Paulo, BR.
      9. 2018. Patient-Reported Symptom Burden of Long-term Head and Neck Cancer Survivors. Conference. International Federation of Head and Neck Oncologic Society 2018 (IFHNOS). Buenos Aires, AR.
      10. 2018. Surgical Airway Management. Invited. Instituto Nacional de Enfermedades Neoplásicas (INEN). Lima, PE.
      11. 2017. Current and Future Trends in Oral Cavity Cancer; Management of Advanced Differentiated Thyroid Carcinoma. Invited. Sichuan Cancer Hospital & Institute. Chengdu, CN.
      12. 2016. Poster Presentation: Decisional Regret in Long-term Oropharyngeal Carcinoma Survivors. Conference. American Head and Neck Society 9th International Conference on Head and Neck Cancer. Seattle, US.
      13. 2016. Complications and Hospital Length of Stay after Total Laryngectomy. Conference. American Head and Neck Society 9th International Conference on Head and Neck Cancer. Seattle, US.
      14. 2014. Poster Presentation: Trans-oral Robotic Surgery (TORS) and Surgeon-Performed Trans-oral Ultrasound For Intraoperative Location and Excision of an Isolated Retropharyngeal Lymph Node Metastasis of Papillary Thyroid Carcinoma. Conference. 1st International TransOral Robotic Surgery Conference. Philadelphia, US.
      15. 2012. Recurrence of Head and Neck Cutaneous Melanoma After Negative Sentinel Lymph Node Biopsy. Conference. American Head and Neck Society 8th International Conference on Head and Neck Cancer. Toronto, CA.

      Formal Peers

      1. 2019. Management of Oral and Oropharyngeal Carcinoma. Invited. Houston, TX, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Townes, TG, Martinez, J, Gross, N, Li, G, Goepfert, RP, Myers, JN, Sikora, AG, Choi, KY, Hutcheson, KA, Song, W, Lee, A, Moran, A, Lewis, CM, Akhave, NS, Johnson, FM, De Sousa, LG, Maniakas, A, Wang, RJ, Su, SY, Lai, SY, Hanna, EY, Zhao, X, Lango, MN. A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown Primary. Otolaryngology - Head and Neck Surgery (United States) 175(2):385-393, 2026. e-Pub 2026. PMID: 42059064.
      2. Devireddy, A, Yi, Y, Nordlund, KN, Lin, R, Salem, AF, Yang, NX, Keatts, SA, Jerez, O, Farooqi, AS, Bishop, AJ, Guadagnolo, BA, Nagarajan, P, Weiser, R, Fisher, SB, Goepfert, RP, Ross, MI, Amaria, RN, Glitza, IC, Yoder, A, Mitra, D. The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis. Annals of surgical oncology 33(8):7461-7470, 2026. e-Pub 2026. PMID: 42189441.
      3. Yang NX, Rosamilia GL, Arifin AJ, Salem AF, Yoder AK, Keatts SA, Jerez O, Lin R, Bishop AJ, Farooqi AS, Weiser R, Ross MI, Mericli AF, Guadagnolo BA, Goepfert RP, Mitra D. Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma. Pract Radiat Oncol, 2025. e-Pub 2025. PMID: 41380909.
      4. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallon de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature 646(8084):462-473, 2025. e-Pub 2025. PMID: 40836096.
      5. Siqueira JM, Heguedusch D, Cunha MT, de Sousa LG, Marques-Piubelli ML, Carvalho GL, Hoff CO, Bonini F, Mitani Y, Spiotto MT, Goepfert R, Nunes FD, Matos LL, Kowalski LP, McGrail DJ, El-Naggar AK, Ferrarotto R. Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment composition. Oral Oncol 169:107634, 2025. e-Pub 2025. PMID: 40865331.
      6. Burton, EM, Milton, D, Tetzlaff, M, Wani, K, Ross, MI, Postow, MA, Segura Lazcano, R, Glitza, IC, Wong, MK, Patel, SP, Diab, A, Gershenwald, JE, McQuade, JL, Warner, AB, Prieto, V, Lee, JE, Goepfert, RP, Fisher, SB, Song, A, Malke, J, Simon, JM, Ariyan, C, Torres Cabala, CA, Davies, MA, Lazar, A, Wargo, J, Tawbi, H, Amaria, RN. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma. Journal of Clinical Oncology 43(26):2856-2862, 2025. e-Pub 2025. PMID: 40638872.
      7. Fournier I, Bandi AV, Hamidi S, Iyer P, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Waguespack SG, Basmaci UN, Williams MD, Mansour M, Monroe MG, Gross ND, Goepfert RP, Perrier ND, Banuchi V, Wang JR, Maniakas A, Zafereo ME. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head Neck 48(1):237-245, 2025. e-Pub 2025. PMID: 40891104.
      8. Lu, T, Anthony, C, Jiang, X, Ning, J, Goepfert, RP, Esmaeli, B. Timing of nodal metastasis in patients with eyelid sebaceous carcinoma and implications for surveillance and survival. British Journal of Ophthalmology 109(8):903-908, 2025. e-Pub 2025. PMID: 40010760.
      9. Mitani, Y, Al-Maghrabi, H, Karpinets, T, Relator, R, Hilder, L, Chen, IY, Goepfert, RP, Bell, D, Zhang, J, Ferrarotto, R, El-Naggar, AK. Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity. Journal of Pathology 266(3):258-267, 2025. e-Pub 2025. PMID: 40272378.
      10. Kaffey, Z, Mirbahaeddin, S, Wahid, K, Kamel, S, Vouffo, M, Otun, AO, Belal, Z, Aponte Wesson, R, Carriere, P, Dede, C, Maniakas, A, Goepfert, RP, Garden, AS, Lee, A, Choi, KY, Christensen, JM, Lincoln, C, Manzar, G, Dudzinski, SO, Thomas, R, Mehrens, H, Cardoso, R, Schellingerhout, D, Watson, E, Chen, MM, Lai, SY, Fuller, C, Moreno, AC, Humbert-Vidan, L. Radiographic classification of mandibular osteoradionecrosis. Radiotherapy and Oncology 208, 2025. e-Pub 2025. PMID: 40320174.
      11. Holsinger, F, Ismaila, N, Adkins, D, Barber, B, Burnette, G, Fakhry, C, Galloway, TJ, Goepfert, RP, Miles, BA, Paleri, V, Patel, AA, Roof, S, Starmer, HM, Yom, SS, Saba, NF, Li, RJ, Ku, JA. Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma. Journal of Clinical Oncology 43(11):1369-1392, 2025. e-Pub 2025. PMID: 39933131.
      12. Sahin, O, Kamel, S, Wahid, K, Dede, C, Taku, N, He, R, Naser, M, Sharafi, CS, Mäkitie, AA, Kann, BH, Kaski, K, Sahlsten, J, Jaskari, J, Amit, M, Chronowski, G, Diaz Jr, EM, Garden, AS, Goepfert, RP, Guenette, JP, Gunn, GB, Hirvonen, J, Hoebers, F, Hutcheson, KA, Guha-Thakurta, N, Johnson, JM, Kaya, D, Khanpara, SD, Nyman, K, Lai, SY, Lango, MN, Learned, KO, Lee, A, Lewis, CM, Maniakas, A, Moreno, AC, Myers, JN, Phan, J, Pytynia, KB, Rosenthal, D, Sandulache, VC, Schellingerhout, D, Shah, SJ, Sikora, AG, Mohamed, AS, Chen, MM, Fuller, C. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography. Cancer 131(7), 2025. e-Pub 2025. PMID: 40159431.
      13. Patel, R, Gopalakrishnan, V, Amini, B, Lazar, A, Lin, PP, Benjamin, RS, Bishop, AJ, Goepfert, RP, Araujo, DM. Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma. Cancers 16(23), 2024. e-Pub 2024. PMID: 39682304.
      14. Keatts SA, Salem AF, Swanson DM, Farooqi AS, Bishop AJ, Amaria RN, McQuade JL, Glitza Oliva IC, Diab A, Weiser R, Fisher SB, Goepfert RP, Ross MI, Ashleigh Guadagnolo B, Mitra D. Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma. Clin Transl Radiat Oncol 49:100856, 2024. e-Pub 2024. PMID: 39308633.
      15. Working Group MOCEEA, Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2024. e-Pub 2024. PMID: 36865096.
      16. Goldfarb J, Fan J, de Sousa LG, Akhave N, Myers J, Goepfert R, Manisundaram K, Zhao J, Frank SJ, Moreno A, Ferrarotto R, Esmaeli B. Neoadjuvant Chemotherapy Alone or Combined with EGFR-Directed Targeted Therapy or Anti-PD-1 Immunotherapy for Locally Advanced Lacrimal Sac and Nasolacrimal Duct Carcinomas. Semin Ophthalmol:1-7, 2024. e-Pub 2024. PMID: 38500295.
      17. Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol 14(5):e373-e382, 2024. e-Pub 2024. PMID: 38851534.
      18. Cass S, Cope B, Bishop AJ, Chiang YJ, Ashleigh Guadagnolo B, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol 188:109892, 2023. e-Pub 2023. PMID: 37659660.
      19. Dohopolski MJ, Diao K, Hutcheson KA, Akhave NS, Goepfert RP, He W, Lei XJ, Peterson SK, Shen Y, Sumer BD, Smith BD, Sher DJ. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 149(8):697-707, 2023. e-Pub 2023. PMID: 37382943.
      20. Yoder AK, Farooqi AS, Wernz C, Subramaniam A, Ravi V, Goepfert R, Sturgis EM, Mitra D, Bishop AJ, Guadagnolo BA. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck 45(8):1943-1951, 2023. e-Pub 2023. PMID: 37272774.
      21. Baruch EN, Nagarajan P, Gleber-Netto FO, Rao X, Xie T, Akhter S, Adewale A, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich S, Calin GA, Migden MR, Vermeer P, D'Silva N, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Gross ND, Amit M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Res Sq, 2023. e-Pub 2023. PMID: 37503252.
      22. Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. ASO Visual Abstract. Annals of surgical oncology 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
      23. Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2331-2338, 2023. e-Pub 2023. PMID: 36581726.
      24. Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
      25. Goldfarb JA, Ferrarotto R, Gross N, Goepfert R, Debnam JM, Gunn B, Nagarajan P, Esmaeli B. Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma. Br J Ophthalmol 107(3):320-323, 2023. e-Pub 2023. PMID: 34625433.
      26. Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NL. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck 45(3):547-554, 2023. e-Pub 2023. PMID: 36524701.
      27. Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, Head MD, Working Group NCS. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Med 12(4):5088-5098, 2023. e-Pub 2023. PMID: 36229990.
      28. Aggarwal P, Nader ME, Gidley PW, Pratihar R, Jivani S, Garden AS, Mott FE, Goepfert RP, Ogboe CW, Charles C, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Hutcheson KA, Shete S. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med 12(1):569-583, 2023. e-Pub 2023. PMID: 35695117.
      29. Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
      30. Fitzgerald CWR, Davies JC, de Almeida JR, Rich JT, Orsini M, Eskander A, Monteiro E, Mimica X, Mclean T, Cracchiolo JR, Ganly I, Hessel A, Tam S, Wei D, Goepfert R, Su J, Xu W, Zafereo M, Goldstein DP, Cohen MA. Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study. Oral Oncol 134:106089, 2022. e-Pub 2022. PMID: 36057225.
      31. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer 128(18):3383-3391, 2022. e-Pub 2022. PMID: 35792683.
      32. Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):1945998211059967, 2022. e-Pub 2022. PMID: 34784256.
      33. Taku N, Chronowski G, Brandon Gunn G, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 113(5):1054-1062, 2022. e-Pub 2022. PMID: 35504500.
      34. Aggarwal P, Hutcheson KA, Yu R, Wang J, Fuller CD, Garden AS, Goepfert RP, Rigert J, Mott FE, Lu C, Lai SY, Gunn GB, Chambers MS, Li G, Wu CC, Hanna EY, Sturgis EM, Shete S. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep 12(1):6662, 2022. e-Pub 2022. PMID: 35459784.
      35. Ferrarotto R, Amit M, Nagarajan P, Rubin ML, Yuan Y, Bell D, El-Naggar AK, Johnson JM, Morrison WH, Rosenthal DI, Glisson BS, Johnson FM, Lu C, Mott FE, Esmaeli B, Diaz EM, Gidley PW, Goepfert RP, Lewis CM, Weber RS, Wargo JA, Basu S, Duan F, Yadav SS, Sharma P, Allison JP, Myers JN, Gross ND. Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res 28(8):1735, 2022. e-Pub 2022. PMID: 35419587.
      36. Aggarwal P, Hutcheson KA, Goepfert RP, Garden AS, Garg N, Mott FE, Fuller CD, Lai SY, Gunn GB, Chambers MS, Hanna EY, Sturgis EM, Shete S. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck 44(4):952-963, 2022. e-Pub 2022. PMID: 35084077.
      37. Davies JC, Hugh S, Rich JT, de Almeida JR, Gullane PJ, Orsini M, Eskander A, Monteiro E, Mimica X, McGill M, Cohen MA, Cracchiolo JR, Teaima A, Tam S, Wei D, Goepfert R, Zafereo M, Su J, Xu W, Goldstein DP. Association of Pharyngocutaneous Fistula With Cancer Outcomes in Patients After Laryngectomy: A Multicenter Collaborative Cohort Study. JAMA Otolaryngol Head Neck Surg 147(12):1027-1034, 2021. e-Pub 2021. PMID: 34323968.
      38. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Lu C, Goepfert RP, Fuller CD, Lai SY, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete S. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer 127(23):4470-4480, 2021. e-Pub 2021. PMID: 34358341.
      39. Amit M, Liu C, Mansour J, Gleber-Netto FO, Tam S, Baruch EN, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Tsai K, Flores ER, Migden MR, Silverman DA, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer 127(23):4413-4420, 2021. e-Pub 2021. PMID: 34358340.
      40. Barbon CEA, CMKL Y, Alvarez CP, Goepfert RP, Fuller CD, Lai SY, Gross ND, Hutcheson KA. Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis. Head Neck 43(10):2883-2895, 2021. e-Pub 2021. PMID: 34080249.
      41. Ferrarotto R, Amit M, Nagarajan P, Rubin ML, Yuan Y, Bell D, El-Naggar AK, Johnson JM, Morrison WH, Rosenthal DI, Glisson BS, Johnson FM, Lu C, Mott FE, Esmaeli B, Diaz EM, Gidley PW, Goepfert RP, Lewis CM, Weber RS, Wargo JA, Basu S, Duan F, Yadav SS, Sharma P, Allison JP, Myers JN, Gross ND. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res 27(16):4557-4565, 2021. e-Pub 2021. PMID: 34187851.
      42. Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era. Ann Surg Oncol 28(7):3480-3489, 2021. e-Pub 2021. PMID: 33856603.
      43. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Goepfert RP, Duvall A, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Shete S. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 147(7):615-623, 2021. e-Pub 2021. PMID: 33956062.
      44. Aggarwal P, Goepfert RP, Garden AS, Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngol Head Neck Surg 147(5):469-478, 2021. e-Pub 2021. PMID: 33538759.
      45. Amit M, Liu C, Gleber-Netto FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch EN, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer 127(8):1238-1245, 2021. e-Pub 2021. PMID: 33320343.
      46. Christopherson KM, Moreno AC, Elgohari B, Gross N, Ferrarotto R, Mohamed ASR, Brandon Gunn G, Goepfert RP, Mott FE, Shah SJ, David Fuller C, Reddy JP, Frank SJ, Morrison WH, Phan J, Rosenthal DI, Garden AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncol 113:105125, 2021. e-Pub 2021. PMID: 33360375.
      47. Amit M, Liu C, Netto Gleber FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer 144:169-177, 2021. e-Pub 2021. PMID: 33352413.
      48. Pundole X, Jones AL, Tetzlaff MT, Williams MD, Murphy WA, Otun A, Goepfert RP, Davies MA. Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report. Immunotherapy 12(17):1213-1219, 2020. e-Pub 2020. PMID: 32900256.
      49. Boukovalas S, Goepfert RP, Smith JM, Mecham E, Liu J, Zafereo ME, Chang EI, Hessel AC, Hanasono MM, Gross ND, Yu P, Lewin JS, Lewis CM, Diaz EM, Weber RS, Myers JN, Offodile AC. Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center. Cancer 126(22):4905-4916, 2020. e-Pub 2020. PMID: 32931057.
      50. Stieb S, Perez-Martinez I, Mohamed ASR, Rock S, Bajaj N, Deshpande TS, Zaid M, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Reddy JP, Phan J, Morrison WH, Rosenthal DI, Koay EJ, Frank SJ, Fuller CD, Gunn GB, Head MD, Working Group NCS. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors. Clin Transl Radiat Oncol 24:71-78, 2020. e-Pub 2020. PMID: 32642562.
      51. Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol 6(9):1397-1404, 2020. e-Pub 2020. PMID: 32761153.
      52. Townes TG, Navuluri S, Pytynia KB, Gunn GB, Kamal MJ, Gilmore KR, Chapman PH, Bell KV, Fournier DM, Janik MA, Joseph LM, Zendehdel S, Hutcheson KA, Goepfert RP. Assessing Patient-Reported Symptom Burden of Long-Term Head and Neck Cancer Survivors at Annual Surveillance in Survivorship Clinic. Head Neck 42(8):1919-1927, 2020. e-Pub 2020. PMID: 32112621.
      53. Ferrarotto R, Bell D, Rubin ML, Hutcheson KA, Johnson JM, Goepfert RP, Phan J, Elamin YY, Torman DK, Warneke CL, Hessel AC, Garden AS, Myers JN, Johnson FM, Lee JJ, Sikora AG, Gillison ML, Glisson BS, Gross ND. Impact of neoadjuvant durvalumab with or without tremelimumab on CD8+ tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial. Clin Cancer Res 26(13):3211-3219, 2020. e-Pub 2020. PMID: 32269052.
      54. Head MD, Guidelines Consortium NST, members C, Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, CMKL Y, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Wesson RA, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck 42(6):1194-1201, 2020. e-Pub 2020. PMID: 32342541.
      55. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
      56. Stieb S, Mohamed ASR, Deshpande TS, Harp J, Greiner B, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Phan J, Reddy JP, Morrison WH, Rosenthal DI, Frank SJ, Fuller CD, Brandon Gunn G, Head MD, Working Group NCS. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?. Clin Transl Radiat Oncol 22:98-105, 2020. e-Pub 2020. PMID: 32373720.
      57. Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK. Pan-Trk Immunohistochemistry Reliably Identifies ETV6-NTRK3 Fusion in Secretory Carcinoma of the Salivary Gland. Virchows Arch 476(2):295-305, 2020. e-Pub 2020. PMID: 31423558.
      58. Esmaeli B, Rubin ML, Xu S, Goepfert RP, Curry JL, Prieto VG, Ning J, Tetzlaff MT. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications. Am J Surg Pathol 43(12):1701-1710, 2019. e-Pub 2019. PMID: 31425167.
      59. Hutcheson KA, Warneke CL, CMKL Y, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND, Head MD, Working Group NCS. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 145(11):1053-1063, 2019. e-Pub 2019. PMID: 31556933.
      60. Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head Neck 41(11):3880-3894, 2019. e-Pub 2019. PMID: 31441572.
      61. Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid 29(8):1036-1043, 2019. e-Pub 2019. PMID: 31319771.
      62. Bell AH, Prieto VG, Ferrarotto R, Goepfert RP, Myers JN, Weber R, Bell D. Magnifying Glass on Spiradenoma and Cylindroma Histogenesis and Tumorigenesis Using Systematic Transcriptome Analysis. Ann Diagn Pathol 41:14-23, 2019. e-Pub 2019. PMID: 31128548.
      63. Amit M, Hutcheson K, Zaveri J, Lewin J, Kupferman ME, Hessel AC, Goepfert RP, Brandon Gunn G, Garden AS, Ferraratto R, Dave Fuller C, Tam S, Gross ND. Patient-Reported Outcomes of Symptom Burden in Patients Receiving Surgical or Nonsurgical Treatment for Low-Intermediate Risk Oropharyngeal Squamous Cell Carcinoma: A Comparative Analysis of a Prospective Registry. Oral Oncol 91:13-20, 2019. e-Pub 2019. PMID: 30926057.
      64. Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom Burden Associated with Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. JAMA Otolaryngol Head Neck Surg 144(11):1066-1076, 2018. e-Pub 2018. PMID: 30193299.
      65. Heah H, Goepfert RP, Hutcheson KA, Garden AS, Gunn GB, Fuller CD, Lewin JS, Kupferman ME, Holsinger FC, Hessel AC, Gross ND. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma. Head Neck 40(11):2507-2513, 2018. e-Pub 2018. PMID: 30102824.
      66. Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
      67. Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
      68. Goepfert RP, Lewin JS, Barrow MP, Warneke CL, Fuller CD, Lai SY, Weber RS, Hutcheson KA. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia 33(2):185-191, 2018. e-Pub 2018. PMID: 28836005.
      69. Head MD, Working Group NCS, Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB. Patient Reported Dry Mouth: Instrument Comparison and Model Performance for Correlation with Quality of Life in Head and Neck Cancer Survivors. Radiother Oncol 126(1):75-80, 2018. e-Pub 2018. PMID: 29229507.
      70. Head MD, Working Group NCS, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):186, 2017. e-Pub 2017. PMID: 29169353.
      71. Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck 39(11):2151-2158, 2017. e-Pub 2017. PMID: 28736965.
      72. Head MD, Working Group NCS, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
      73. Goepfert RP, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC, Lewis CM, Weber RS, Gross ND. Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123(10):1760-1767, 2017. e-Pub 2017. PMID: 28026864.
      74. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope 127(4):842-848, 2017. e-Pub 2017. PMID: 27440393.
      75. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2017. PMID: 27485284.
      76. Goepfert RP, Liu C, Ryan WR. Trans-oral robotic surgery and surgeon-performed trans-oral ultrasound for intraoperative location and excision of an isolated retropharyngeal lymph node metastasis of papillary thyroid carcinoma. Am J Otolaryngol 36(5):710-4, 2015. e-Pub 2015. PMID: 25964171.
      77. Davis-Malesevich MV, Goepfert R, Kubik M, Roberts DB, Myers JN, Kupferman ME. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy. Head Neck 37(8):1116-21, 2015. e-Pub 2015. PMID: 24764188.
      78. Goepfert RP, Yom SS, Ryan WR, Cheung SW. Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma. Laryngoscope 125(4):869-76, 2015. e-Pub 2015. PMID: 25388529.
      79. Goepfert RP, Kezirian EJ, Wang SJ. Oral tongue squamous cell carcinoma in young women: a matched comparison-do outcomes justify treatment intensity?. ISRN Otolaryngol 2014:529395, 2014. e-Pub 2014. PMID: 24734200.

      Review Articles

      1. Kamal M, Baudo M, Shmushkevich S, Geng Y, Hanna E, Goepfert RP, Lewis CM, Rahouma M. COVID-19 infection and its consequences among surgical oncology patients: A systematic analysis, meta-analysis and meta-regression. J Surg Oncol 125(5):813-823, 2022. e-Pub 2022. PMID: 35014703.
      2. Goepfert RP, Myers JN, Gershenwald JE. Updates in the evidence-based management of cutaneous melanoma. Head Neck 42(11):3396-3404, 2020. e-Pub 2020. PMID: 33463835.
      3. Goepfert RP, Clayman GL. Management of the Central Compartment in Differentiated Thyroid Carcinoma. Eur J Surg Oncol 44(3):327-331, 2018. e-Pub 2018. PMID: 28964612.

      Book Chapters

      1. Goepfert RP, Hutcheson KA, Gross ND. Functional Outcomes after Transoral Robotic Surgery. In: Atlas of Robotic and Endoscopic Head and Neck Surgery. Springer Nature, 2019.
      2. Goepfert RP. Neck Dissection and Parotidectomy for Melanoma. In: Cutaneous Melanoma. Springer Nature, 2019.
      3. Goepfert RP, Zafereo ME. Cancers of the Head and Neck. In: The MD Anderson Surgical Oncology Handbook. Wolters Kluwer, 2018.
      4. Goepfert RP, Kupferman ME. Robotic Instrumentation, Personnel, and Operating Room Setup. In: Atlas of Head and Neck Robotic Surgery. Springer International Publishing, 2017.
      5. Goepfert RP, Orloff LA. Imaging I: Ultrasound. In: Parathyroid Surgery: Fundamental and Advanced Concepts. Plural Publishing, 2014.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 12, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Head & Neck Surgery

      • Head & Neck Center

      • Oral Cancer

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top